Diabetes drugs Byetta and Januvia are causing an increase in pancreatic cancer among patients. As a result, multiple victims are filing lawsuits after suffering adverse effects from Byetta and Januvia across the country. The fact that so many lawsuits have been filed has prompted attorneys to ask that Byetta and Januvia pancreatic cancer lawsuits be consolidated in U.S. courts.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) is responsible for determining whether or not civil court cases that are pending in multiple locations throughout the country should be transferred to one federal district court for pre-trial proceedings. This is normally done in an effort to streamline court proceedings and make it easier for victims to receive compensation. One group of California litigants has asked that all lawsuits concerning any of the aforementioned drugs be consolidated and heard in U.S. District Court for the Southern District of California.
The JPML will hear oral arguments concerning the consolidation of these cases on May 30 at the federal courthouse located at 601 West Broadway in Louisville, Kentucky. Attorneys who are representing interested parties will appear at 8:30 a.m., with oral arguments beginning at precisely 9:30 a.m. This hearing is open to members of the public.
It may take some time for the panel of judges to reach a decision in this matter. Even if these cases are consolidated, it will not affect a patient’s ability to recover damages, even if he or she does not reside in California. We will still be available and ready to help individuals from accross the country receive the compensation they are entitled to no matter how this decision plays out. If you or a loved one has developed pancreatic cancer after taking Byetta or Januvia, contact us to protect your rights.